Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) shares gapped down prior to trading on Tuesday following a dissappointing earnings announcement. The stock had previously closed at $108.84, but opened at $99.75. Addus HomeCare shares last traded at $99.90, with a volume of 65,541 shares traded.
The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million.
Analyst Upgrades and Downgrades
Several research firms have commented on ADUS. Citizens Jmp upgraded Addus HomeCare to a "strong-buy" rating in a research note on Monday, December 16th. StockNews.com cut Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday. JMP Securities began coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an "outperform" rating and a $150.00 target price on the stock. Oppenheimer boosted their target price on Addus HomeCare from $145.00 to $150.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. Finally, Stephens dropped their price objective on Addus HomeCare from $153.00 to $142.00 and set an "overweight" rating on the stock in a research note on Wednesday. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Addus HomeCare presently has a consensus rating of "Moderate Buy" and a consensus price target of $132.78.
View Our Latest Analysis on Addus HomeCare
Insider Activity at Addus HomeCare
In related news, EVP Roberton James Stevenson sold 2,250 shares of the stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the sale, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This trade represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by company insiders.
Institutional Investors Weigh In On Addus HomeCare
Large investors have recently added to or reduced their stakes in the business. Quarry LP bought a new stake in Addus HomeCare in the 3rd quarter valued at $28,000. Natixis grew its holdings in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after buying an additional 132 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in Addus HomeCare by 324.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 280 shares of the company's stock valued at $35,000 after buying an additional 214 shares in the last quarter. Farther Finance Advisors LLC grew its holdings in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company's stock valued at $49,000 after buying an additional 366 shares in the last quarter. Finally, Parkside Financial Bank & Trust grew its holdings in Addus HomeCare by 38.6% in the 4th quarter. Parkside Financial Bank & Trust now owns 531 shares of the company's stock valued at $67,000 after buying an additional 148 shares in the last quarter. Institutional investors own 95.35% of the company's stock.
Addus HomeCare Stock Performance
The business has a fifty day simple moving average of $122.60 and a 200 day simple moving average of $126.08. The stock has a market capitalization of $1.74 billion, a price-to-earnings ratio of 21.92, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.